Related Experiment Video

Updated: Apr 7, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.2K

γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

Jaydeep Bhat1, Dieter Kabelitz1

  • 1Institute of Immunology; University of Kiel and UKSH Campus Kiel ; Kiel, Germany.

Oncoimmunology
|July 9, 2015
PubMed

Insights

Combining epigenetic drugs with gamma-delta T cell (γδ T cell) therapy shows promise for cancer immunotherapy. This approach may enhance tumor cell death and boost the immune response against cancer.

Area of Science:

  • Immunology
  • Oncology
  • Epigenetics

Background:

  • Current gamma-delta T cell (γδ T cell) immunotherapies for cancer have limited efficacy.
  • Epigenetic drugs targeting histone acetylation and DNA methylation induce tumor cell death.
  • These epigenetic drugs also possess immunomodulatory properties.

Purpose of the Study:

  • To explore the potential of combining γδ T cell therapy with epigenetic drugs.
  • To investigate synergistic effects in cancer immunotherapy.

Main Methods:

  • Discussion of existing research on γδ T cells.
  • Review of epigenetic drugs (histone deacetylase inhibitors, DNA methyltransferase inhibitors).
  • Analysis of potential combination strategies.

Main Results:

  • Epigenetic drugs can enhance anti-tumor immunity.
  • Combination therapy may overcome limitations of current immunotherapies.
  • Potential for increased tumor cell apoptosis and immune cell activation.

Conclusions:

  • Combining epigenetic drugs with γδ T cell therapy is a promising strategy.
  • This approach could improve cancer immunotherapy outcomes.
  • Further research is warranted to optimize combination protocols.
Keywords:
DNMTi, DNA methyltransferase inhibitor(s)HDACi, histone deacetylase inhibitor(s)IL-2, interleukin-2N-BP, nitrogen-containing bisphosphonateNKG2D, natural killer group 2 member DNSCLC, non-small cell lung cancerepigenetic drugshistone deacetylase inhibitorimmunotherapytumor cellγδ T cells

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.9K
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

2.0K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.2K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.4K